JESSICA BORDELON: Open Payments
NPI 1043585854 · HAMMOND, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,622 in 119 payments from 43 companies in 2025. Trend: 2023 $23,175 · 2024 $12,233 · 2025 $2,622
Food & beverage: $2,523Education: $99
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $192 |
| Novartis Pharmaceuticals Corporation | 9 | $189 |
| Janssen Biotech, Inc. | 9 | $179 |
| PFIZER INC. | 8 | $156 |
| Aveo Pharmaceuticals, Inc. | 3 | $154 |
| TerSera Therapeutics LLC | 4 | $111 |
| GENZYME CORPORATION | 3 | $83 |
| ABBVIE INC. | 3 | $77 |
| Celgene Corporation | 3 | $74 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $69 |
Products named: FOTIVDA, Xermelo, KISQALI, IBRANCE, Xtandi, Enhertu, OPDIVO, SCEMBLIX.
Industry payments across LA — which companies pay providers there.
